Data / Drug companies / Maithri Laboratories Private Limited
Maithri Laboratories Private Limited: 24 products in the FDA NDC directory, labeler code 71666
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Maithri Laboratories Private Limited (labeler code 71666) lists 24 products in the FDA National Drug Code Directory. By type: 24 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 29, 2026.
The request: Watch Maithri Laboratories Private Limited (FDA labeler code 71666): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71666
- Products in commercial distribution
- 24
- Packages
- 24
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 2, Schedule V 1
- Started marketing in the last 12 months
- 6
- Earliest marketing start
- August 28, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 24 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Apixaban | 71666-025 | Powder | Bulk ingredients | March 29, 2026 |
| Elafibranor | 71666-024 | Powder | Bulk ingredients | March 29, 2026 |
| Rebamipide | 71666-021 | Powder | Bulk ingredients | March 29, 2026 |
| Suvorexant | 71666-023 | Powder | Bulk ingredients | March 28, 2026 |
| Daridorexant hydrochloride | 71666-020 | Powder | Bulk ingredients | March 28, 2026 |
| Rabeprazole sodium | 71666-022 | Powder | Bulk ingredients | March 27, 2026 |
| Betahistine hydrochloride | 71666-018 | Powder | Bulk ingredients | March 29, 2025 |
| Gepirone hydrochloride | 71666-019 | Powder | Bulk ingredients | March 25, 2025 |
| Escitalopram oxalate | 71666-017 | Powder | Bulk ingredients | March 20, 2025 |
| Lumateperone tosylate | 71666-016 | Powder | Bulk ingredients | September 20, 2023 |
| Viloxazine hydrochloride | 71666-015 | Powder | Bulk ingredients | August 25, 2023 |
| Buspirone hydrochloride | 71666-013 | Powder | Bulk ingredients | March 28, 2023 |
| Salcaprozate sodium | 71666-012 | Powder | Bulk ingredients | March 19, 2021 |
| Pyridostigmine bromide | 71666-011 | Powder | Bulk ingredients | August 14, 2020 |
| Cysteamine bitartrate | 71666-010 | Powder | Bulk ingredients | April 24, 2020 |
| Tolterodine tartrate | 71666-009 | Powder | Bulk ingredients | March 28, 2020 |
| Valganciclovir hydrochloride | 71666-008 | Powder | Bulk ingredients | February 28, 2020 |
| Brivaracetam | 71666-007 | Powder | Bulk ingredients | March 29, 2019 |
| Chlorpromazine hydrochloride | 71666-006 | Powder | Bulk ingredients | November 29, 2018 |
| Ivabradine hydrochloride | 71666-003 | Powder | Bulk ingredients | October 22, 2018 |
| Fesoterodine fumarate | 71666-005 | Powder | Bulk ingredients | September 29, 2018 |
| Eliglustat tartrate (premix) | 71666-002 | Powder | Bulk ingredients | March 28, 2018 |
| Eliglustat tartrate | 71666-004 | Powder | Bulk ingredients | March 27, 2018 |
| Flucytosine | 71666-001 | Powder | Bulk ingredients | August 28, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.